Characterization of Host Cell DNA Impurities in AAV Products: A Product Specific Qualification Method & DNA Fragment Size Assessment

2:15 pm - Thursday 3rd December 2026

  • rAAV as a Gene Therapy Product
  • Gene Therapy Critical Quality Attributes (CQA)
  • Overview Methods for Residual Host Cell DNA Quantification
  • Method Development for Residual Host Cell DNA Quantification
  • Residual Host Cell DNA Sizing in rAAV Gene Therapy Product

Speakers:

Principal Research Associate, Analytical Development
Astellas Gene Therapies